You are here

Abiomed

Abiomed plunges 30% on federal investigation into Impella marketing

Thu, 11/1/12 - 10:25 pm

Abiomed touts positive results for its Symphony heart pump

Wed, 10/24/12 - 10:25 pm

clinical trials

Abiomed Receives FDA 510(k) Clearance for New, Higher Flow Impella Percutaneous Heart Pump, With Peak Flows of 4L/min

Mon, 09/10/12 - 10:59 pm

Abiomed lands new insurance codes for Impella heart pumps

Sat, 09/8/12 - 02:41 pm

Abiomed Announces Publication of PROTECT II Study in Circulation: Journal of the American Heart Association

Wed, 09/5/12 - 10:04 pm

Abiomed founder, cardiovascular pioneer, dies of cancer

Mon, 08/20/12 - 11:27 pm

Percutaneous Coronary Intervention (PCI) Surgical Device from Abiomed (ABMD) Approved in Europe and Canada: CEO Sees 30% Growth Rate Continuing

Wed, 08/15/12 - 09:34 pm

Abiomed Announces Record Revenue of $38.8 Million, Up 42% and Worldwide Impella Revenue Growth of 56%

Thu, 08/2/12 - 12:13 pm

Thoratec Reports Mixed Q2; Abiomed Waits In Wings

Wed, 08/1/12 - 06:25 pm

Abiomed Misses Where It Counts

Tue, 05/22/12 - 10:55 pm

Abiomed posts 4Q profit; shares rise on outlook

Wed, 05/16/12 - 01:16 pm

HeartWare's FDA nod is good news for rivals Abiomed, Thoratec

Thu, 04/26/12 - 10:18 pm

UPDATE 1-Abiomed's heart pump gets EU nod

Thu, 04/12/12 - 10:04 pm

Abiomed Receives CE Mark for Impella cVAD

Thu, 04/12/12 - 10:00 pm

Abiomed Appoints Susan Vissers Lisa as Senior Director of Investor Relations and Corporate Development

Wed, 03/21/12 - 10:39 pm

Outperform on Abiomed

Thu, 02/9/12 - 10:02 pm

Abiomed surges on record-breaking Q3 sales and street-beating profits

Fri, 02/3/12 - 05:35 pm

Thoratec gears up to compete with Abiomed

Mon, 01/9/12 - 11:07 pm

Abiomed announces new Impella device, plan for Japan

Mon, 12/19/11 - 06:25 pm

Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives

Fri, 12/9/11 - 06:58 pm

Pages